/ / New program - Credence

New program - Credence

New program - Credence

"Credence" is a unique infertility treatment program with the use of donor oocytes. 100% refund is guaranteed if the pregnancy is not achieved following two or three IVF cycles. 

The program is designed to protect our patients in the best possible way, allowing to receive the best results with a maximum treatment payback. It helps significantly mitigate financial risks associated with unsuccessful IVF treatment with donor oocytes and lets the patients plan their expenses easily, knowing the program’s fixed fee (1 fresh embryo + 1 or 2 vitrified ones).

In cases where complete treatment cycle does not result in a pregnancy after 2 or 3 fertilization attempts depending on the program type, the patient receives a full refund of the program fee.

It is important to keep in mind that there are so-called exclusionary criteria, i.e. the list of medical constraints preventing the patient from using this program. These are:

  • congenital abnormalities of the uterus;
  • Asherman's syndrome and/or intrauterine adhesion which cannot be corrected surgically;
  • endometrial hypoplasia (hypotrophy);
  • uterine hypoplasia of III-IV degree;
  • recurrent miscarriage;
  • multiple (at least 2) unsuccessful attempts of IVF with donor eggs, which includes spontaneous miscarriage during the 1st trimester;
  • severe male factor infertility;
  • high risk of pregnancy loss during the 1st trimester.

The services listed below are included in the program: IVF with donor oocytes and medications for the recipient - 1 attempt; vitrification of embryos and their storage for 18 months; sperm vitrification and its storage for 18 months; IVF with vitrified embryos and medications for the recipient – 1 or 2 attempts, depending on the program type; intracytoplasmic injection of one sperm cell (ICSI); embryo cultivation to the blastocyst stage; ultrasound monitoring during the entire treatment cycle; monitoring of the hormones during the entire treatment cycle; stay in a day-patient department after the embryo transfer; professional medical advice during treatment cycle; pregnancy tests, including determination of chorionic gonadotropic hormone in the blood and transvaginal ultrasound during the treatment cycle.

Fee: Credence Program 2 Attempts – EUR 9,557; Credence Program 3 Attempts – EUR 10,673.